Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The background to this study began with the reporting of two Japanese kindreds with the S305N tau mutation. Although the pathological findings in the autopsied cases were well characterized, only limited ante-mortem data were presented. In this study, longitudinal characterization was carried out in two siblings of European ancestry found to have frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) through comprehensive neurobehavioural examinations and other scales at approximate 6-month intervals. Scales included the Mini-Mental State Examination, Short Test of Mental Status, modified motor subtest of the Unified Parkinson's Disease Rating Scale, detailed neuropsychological testing, and the Neuropsychiatric Inventory. Changes in whole-brain volume and ventricular volume were measured from serial MRI studies. All members of the kindred underwent molecular genetic analyses to elucidate the mechanism of inheritance. The missense mutation in tau, S305N, was detected in the proband (onset age 30), who has undergone serial evaluations for almost 4 years. Her older sister (onset age 36) was subsequently found to have the same mutation, and has undergone serial evaluations for 2 years. This mutation is absent in both parents and the only other sibling, and non-paternity was excluded by additional analyses. The siblings have exhibited cognitive and behavioural features typical of FTDP-17, which have proved challenging to manage despite aggressive pharmacological and behavioural therapies. The proband's sister has demonstrated an atypical profile of impairment on neuropsychological testing. Both siblings have developed striking atrophy of the anterior part of temporal lobes and moderate atrophy of the dorsolateral and orbitofrontal cortical regions, which in both cases is relatively symmetrical. The annualized changes in whole-brain volume and ventricular volume, respectively, were -35.2 ml/year (3.23% decrease per year) and +20.75 ml/year (16.93% increase per year) for the proband, and -30.75 ml/year (2.77% decrease per year) and +5.01 ml/year (3.11% increase per year) for the proband's sister. In conclusion, the mutation in these siblings may have arisen during oogenesis in the mother and probably represents germline mosaicism. Although both patients have exhibited the typical cognitive and behavioural features of FTDP-17, one patient is exhibiting an atypical neuropsychological profile. Also, despite a similar topographic pattern of progressive atrophy on MRI, the rates of change in whole-brain volume and ventricular volume between the two patients are quite different. These findings have implications for future drug trial development in FTDP-17 and the sporadic tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 1×
“MAPT (the gene encoding tau) analysis was performed as previously described (Spillantini et al., 1998).”
MethodSelf-citationRates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937 · cited 1×
“…been refining techniques to quantify rates of regional or whole-brain atrophy using MRI in patients with mild cognitive impairment and Alzheimer’s disease (Jack et al., 1998, 2000, 2003; Fox et al., 1999, 2000; Gunter et al., 2003), and more recently in patients with FTD (Chan et al., 2001a, b).”
MethodSelf-citationPatterns of brain atrophy in frontotemporal dementia and semantic dementia
Rosen, H. J., Gorno–Tempini, M. L., Goldman, W. P., Perry, R. J., Schuff, N., Weiner, M., Feiwell, R., Kramer, J. H., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.58.2.198 · Cited by 841
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease
Chan, D., Fox, N. C., Scahill, R. I., Crum, W. R., Whitwell, J. L., Leschziner, G., Rossor, A. M., Stevens, J. M., Cipolotti, L., & Rossor, M. N. (2001) · Annals of Neurology · doi:10.1002/ana.92 · Cited by 749 · cited 2×
“…been refining techniques to quantify rates of regional or whole-brain atrophy using MRI in patients with mild cognitive impairment and Alzheimer’s disease (Jack et al., 1998, 2000, 2003; Fox et al., 1999, 2000; Gunter et al., 2003), and more recently in patients with FTD (Chan et al., 2001a, b).”
MethodRate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1998) · Neurology · doi:10.1212/wnl.51.4.993 · Cited by 666 · cited 1×
“…been refining techniques to quantify rates of regional or whole-brain atrophy using MRI in patients with mild cognitive impairment and Alzheimer’s disease (Jack et al., 1998, 2000, 2003; Fox et al., 1999, 2000; Gunter et al., 2003), and more recently in patients with FTD (Chan et al., 2001a, b).”
MethodPathologic heterogeneity in clinically diagnosed corticobasal degeneration
Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., Dickson, D. W., Kokmen, E., & Petersen, R. C. (1999) · Neurology · doi:10.1212/wnl.53.4.795 · Cited by 417
Self-citationThe temporal variant of frontotemporal dementia
Edwards-Lee, T. (1997) · Brain · doi:10.1093/brain/120.6.1027 · Cited by 373
Hodges, J. R., Patterson, K., Ward, R., Garrard, P., Bak, T., Perry, R., & Gregory, C. (1999) · Neuropsychology · doi:10.1037/0894-4105.13.1.31 · Cited by 335 · cited 2×
“…Miller, 2001b), poor performance in confrontation naming in the setting of more normal performance on other measures (particularly memory) may suggest underlying FTD rather than AD (Boone et al., 1999; Hodges et al., 1999; Miller and Gearhart, 1999; Hodges and Miller, 2001b; Boccardi et al., 2003).”
BackgroundCytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181 · cited 3×
“CSF tau has been consistently elevated in Alzheimer’s disease, often exceeding levels in FTD (Arai et al., 1997; Green et al., 1999; Molina et al., 1999; Sjögren et al., 2000a, b; Vanmechelen et al., 2001; Riemenschneider et al., 2002).”
BackgroundResultCerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
Arai, H., Morikawa, Y.-I., Higuchi, M., Matsui, T., Clark, C. M., Miura, M., Machida, N., Lee, V. M.-Y., Trojanowski, J. Q., & Sasaki, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6908 · Cited by 159 · cited 4×
“CSF tau has been consistently elevated in Alzheimer’s disease, often exceeding levels in FTD (Arai et al., 1997; Green et al., 1999; Molina et al., 1999; Sjögren et al., 2000a, b; Vanmechelen et al., 2001; Riemenschneider et al., 2002).”
BackgroundResultInfluentialComparison of neuropsychological functioning in Alzheimer’s disease and frontotemporal dementia
Pachana, N. A., Boone, K. B., Miller, B. L., Cummings, J. L., & Berman, N. (1996) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700001673 · Cited by 154 · cited 5×
“Much of the research on FTD has centred on features that discriminate FTD from other dementias (Gregory and Hodges, 1996; Mendez et al., 1996, 1998; Pachana et al., 1996; Gregory et al., 1997; Lindau et al., 2000; Mummery et al., 2000; Perry and Hodges, 2000; Hodges and Miller, 2001a; Lough et al.,…”
BackgroundInfluential
Cited by
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Neary, D., Snowden, J., & Mann, D. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70223-4 · Cited by 526
Ghetti, B., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 438
Self-citationNeuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
Whitwell, J. L., Weigand, S. D., Boeve, B. F., Senjem, M. L., Gunter, J. L., DeJesus-Hernandez, M., Rutherford, N. J., Baker, M., Knopman, D. S., Wszolek, Z. K., et al. (2012) · Brain · doi:10.1093/brain/aws001 · Cited by 397
Self-citationParkinsonism, movement disorders and genetics in frontotemporal dementia
Baizabal-Carvallo, J. F., & Jankovic, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.14 · Cited by 121
Metadata
- Authors
- Boeve, B. F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-02-02
- Volume
- 128
- Issue
- 4
- Pages
- 752-772
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2134898935
- Cited by
- 58
- References
- 12
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.